166 related articles for article (PubMed ID: 32078695)
21. Thymosin alpha1 enhanced cytotoxicity of iNKT cells against colon cancer via upregulating CD1d expression.
Ni C; Wu P; Wu X; Zhang T; Zhang T; Wang Z; Zhang S; Qiu F; Huang J
Cancer Lett; 2015 Jan; 356(2 Pt B):579-88. PubMed ID: 25304368
[TBL] [Abstract][Full Text] [Related]
22. Invariant NKT cells increase drug-induced osteosarcoma cell death.
Fallarini S; Paoletti T; Orsi Battaglini N; Lombardi G
Br J Pharmacol; 2012 Dec; 167(7):1533-49. PubMed ID: 22817659
[TBL] [Abstract][Full Text] [Related]
23. Cancer Immunotherapeutic Potential of NKTT320, a Novel, Invariant, Natural Killer T Cell-Activating, Humanized Monoclonal Antibody.
Patel NP; Guan P; Bahal D; Hashem T; Scheuplein F; Schaub R; Nichols KE; Das R
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32560408
[TBL] [Abstract][Full Text] [Related]
24. Function and expression of CD1d and invariant natural killer T-cell receptor in the cotton rat (Sigmodon hispidus).
Fichtner AS; Paletta D; Starick L; Schumann RF; Niewiesk S; Herrmann T
Immunology; 2015 Dec; 146(4):618-29. PubMed ID: 26346465
[TBL] [Abstract][Full Text] [Related]
25. CD1d expression in glioblastoma is a promising target for NKT cell-based cancer immunotherapy.
Hara A; Koyama-Nasu R; Takami M; Toyoda T; Aoki T; Ihara F; Kobayashi M; Hirono S; Matsutani T; Nakayama T; Iwadate Y; Motohashi S
Cancer Immunol Immunother; 2021 May; 70(5):1239-1254. PubMed ID: 33128583
[TBL] [Abstract][Full Text] [Related]
26. Intestinal iNKT cells migrate to liver and contribute to hepatocyte apoptosis during alcoholic liver disease.
Lee KC; Chen P; Maricic I; Inamine T; Hu J; Gong S; Sun JC; Dasgupta S; Lin HC; Lin YT; Loomba R; Stärkel P; Kumar V; Schnabl B
Am J Physiol Gastrointest Liver Physiol; 2019 May; 316(5):G585-G597. PubMed ID: 30817180
[TBL] [Abstract][Full Text] [Related]
27. CD1d-Restricted pathways in hepatocytes control local natural killer T cell homeostasis and hepatic inflammation.
Zeissig S; Peuker K; Iyer S; Gensollen T; Dougan SK; Olszak T; Kaser A; Blumberg RS
Proc Natl Acad Sci U S A; 2017 Sep; 114(39):10449-10454. PubMed ID: 28893990
[TBL] [Abstract][Full Text] [Related]
28. CD1d-independent activation of mouse and human iNKT cells by bacterial superantigens.
Hayworth JL; Mazzuca DM; Maleki Vareki S; Welch I; McCormick JK; Haeryfar SM
Immunol Cell Biol; 2012 Aug; 90(7):699-709. PubMed ID: 22041925
[TBL] [Abstract][Full Text] [Related]
29. Invariant natural killer T cells in lupus patients promote IgG and IgG autoantibody production.
Shen L; Zhang H; Caimol M; Benike CJ; Chakravarty EF; Strober S; Engleman EG
Eur J Immunol; 2015 Feb; 45(2):612-23. PubMed ID: 25352488
[TBL] [Abstract][Full Text] [Related]
30. Anti-CD1d treatment suppresses immunogenic maturation of lung dendritic cells dependent on lung invariant natural killer T cells in asthmatic mice.
Lin Q; Wang T; Zuo X; Ni H; Zhong J; Zhan L; Cheng H; Huang Y; Ding X; Yu H; Nie H
Int Immunopharmacol; 2023 Nov; 124(Pt B):110921. PubMed ID: 37725846
[TBL] [Abstract][Full Text] [Related]
31. A Potent CD1d-binding Glycolipid for iNKT-Cell-based Therapy Against Human Breast Cancer.
Seki T; Liu J; Brutkiewicz RR; Tsuji M
Anticancer Res; 2019 Feb; 39(2):549-555. PubMed ID: 30711929
[TBL] [Abstract][Full Text] [Related]
32. Cd1d regulates B cell development but not B cell accumulation and IL10 production in mice with pathologic CD5(+) B cell expansion.
Palmer VL; Nganga VK; Rothermund ME; Perry GA; Swanson PC
BMC Immunol; 2015 Nov; 16():66. PubMed ID: 26537916
[TBL] [Abstract][Full Text] [Related]
33. Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities.
Wu L; Gabriel CL; Parekh VV; Van Kaer L
Tissue Antigens; 2009 Jun; 73(6):535-45. PubMed ID: 19392798
[TBL] [Abstract][Full Text] [Related]
34. A locus on mouse chromosome 13 inversely regulates CD1d expression and the development of invariant natural killer T-cells.
Tsaih SW; Presa M; Khaja S; Ciecko AE; Serreze DV; Chen YG
Genes Immun; 2015; 16(3):221-30. PubMed ID: 25654212
[TBL] [Abstract][Full Text] [Related]
35. Invariant NKT cells contribute to chronic lymphocytic leukemia surveillance and prognosis.
Gorini F; Azzimonti L; Delfanti G; Scarfò L; Scielzo C; Bertilaccio MT; Ranghetti P; Gulino A; Doglioni C; Di Napoli A; Capri M; Franceschi C; Caligaris-Cappio F; Ghia P; Bellone M; Dellabona P; Casorati G; de Lalla C
Blood; 2017 Jun; 129(26):3440-3451. PubMed ID: 28465341
[TBL] [Abstract][Full Text] [Related]
36. Enhanced Anti-lymphoma Activity of CAR19-iNKT Cells Underpinned by Dual CD19 and CD1d Targeting.
Rotolo A; Caputo VS; Holubova M; Baxan N; Dubois O; Chaudhry MS; Xiao X; Goudevenou K; Pitcher DS; Petevi K; Kachramanoglou C; Iles S; Naresh K; Maher J; Karadimitris A
Cancer Cell; 2018 Oct; 34(4):596-610.e11. PubMed ID: 30300581
[TBL] [Abstract][Full Text] [Related]
37. Low levels of circulating invariant natural killer T cells predict poor clinical outcome in patients with head and neck squamous cell carcinoma.
Molling JW; Langius JA; Langendijk JA; Leemans CR; Bontkes HJ; van der Vliet HJ; von Blomberg BM; Scheper RJ; van den Eertwegh AJ
J Clin Oncol; 2007 Mar; 25(7):862-8. PubMed ID: 17327607
[TBL] [Abstract][Full Text] [Related]
38. Olea europaea pollen lipids activate invariant natural killer T cells by upregulating CD1d expression on dendritic cells.
Abós-Gracia B; del Moral MG; López-Relaño J; Viana-Huete V; Castro L; Villalba M; Martínez-Naves E
J Allergy Clin Immunol; 2013 May; 131(5):1393-9.e5. PubMed ID: 23265858
[TBL] [Abstract][Full Text] [Related]
39. Negative modulation of invariant natural killer T cell responses to glycolipid antigens by p38 MAP kinase.
Stuart JK; Bisch SP; Leon-Ponte M; Hayatsu J; Mazzuca DM; Maleki Vareki S; Haeryfar SM
Int Immunopharmacol; 2010 Sep; 10(9):1068-76. PubMed ID: 20584631
[TBL] [Abstract][Full Text] [Related]
40. Human intestinal and circulating invariant natural killer T cells are cytotoxic against colorectal cancer cells via the perforin-granzyme pathway.
Díaz-Basabe A; Burrello C; Lattanzi G; Botti F; Carrara A; Cassinotti E; Caprioli F; Facciotti F
Mol Oncol; 2021 Dec; 15(12):3385-3403. PubMed ID: 34535957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
